|
Homocystinuria
|
C17.300.428 |
|
|
Cystography
|
E01.370.350.700.830.500 |
|
|
Anacardic Acids
|
D02.455.426.559.389.657.410.595.151 |
|
|
Biliverdine
|
D03.383.129.578.840.249.184.200 |
|
|
Bilirubin
|
D03.383.129.578.840.249.184 |
|
|
Low Density Lipoprotein Receptor-Related Protein-2
|
D23.050.422.500.500 |
|
|
Heymann Nephritis Antigenic Complex
|
D23.050.422.500 |
|
|
Patient Outcome Assessment
|
N05.715.360.575.575.399 |
|
|
3',5'-Cyclic-AMP Phosphodiesterases
|
D12.644.360.008 |
|
|
3',5'-Cyclic-GMP Phosphodiesterases
|
D12.644.360.009 |
|
|
Barbados
|
Z01.639.880.140 |
|
|
SOS Response, Genetics
|
G05.219.830 |
|
|
DNA Repair
|
G05.219 |
|
|
Zygomatic Fractures
|
C10.900.300.284.500.950 |
|
|
Anisakiasis
|
C01.610.335.508.700.100.060 |
|
|
Laboratories, Dental
|
N02.278.192.631 |
|
|
Dental Facilities
|
N02.278.192 |
|
|
Antihypertensive Agents
|
D27.505.954.411.162 |
|
|
Mycoplasma arthritidis
|
B03.440.860.580.553.553.075 |
|
|
Mycoplasma
|
B03.440.860.580.553.553 |
|
